John has a broad-based drug discovery knowledge spanning from preclinical research to early clinical lead optimization to FIH regulatory submissions. While on a job rotation in the Global Regulatory Documentation group, John provided support in authoring regulatory documentation for IND dossiers, including those done in collaboration with external stakeholders. John is intelligent, dependable, focused and organized; he demonstrated an ability to work both independently as well as with a multi-functional team. Most importantly, his solid scientific background and industry knowledge allowed John to seamlessly fit into the new group environment and instantly make a significant contribution. John would make a valuable asset to any organization that pursues the discovery and development of new drugs. I would welcome an opportunity to work with John again in the future.

I worked with John for 8 years in Lead Discovery at BMS. John is an excellent scientist. He is among the most well-read and up-to-date on the relevant scientific literature of any scientists that I know. He not only has a deep understanding of GPCRs (I was struck by this the first time that I met him), but also a surprisingly broad knowledge around other target classes as well — kinases, ion channels, protein-protein interactions, RTKs, etc. John is also an excellent writer and is able to communicate his knowledge clearly and effectively. It has been my pleasure to co-author several publications with him. Strategically, John is adept at proactively identifying and effectively communicating potential pitfalls, providing multiple alternative options and providing very honest and realistic assessments of the potential advantages and disadvantages of any particular approach. He has a witty and insightful personality and is a pleasure to work with.

John has a broad-based drug discovery knowledge spanning from preclinical research to early clinical lead optimization to FIH regulatory submissions. While on a job rotation in the Global Regulatory Documentation group, John provided support in authoring regulatory documentation for IND dossiers, including those done in collaboration with external stakeholders. John is intelligent, dependable, focused and organized; he demonstrated an ability to work both independently as well as with a multi-functional team. Most importantly, his solid scientific background and industry knowledge allowed John to seamlessly fit into the new group environment and instantly make a significant contribution. John would make a valuable asset to any organization that pursues the discovery and development of new drugs. I would welcome an opportunity to work with John again in the future.

I worked with John for 8 years in Lead Discovery at BMS. John is an excellent scientist. He is among the most well-read and up-to-date on the relevant scientific literature of any scientists that I know. He not only has a deep understanding of GPCRs (I was struck by this the first time that I met him), but also a surprisingly broad knowledge around other target classes as well — kinases, ion channels, protein-protein interactions, RTKs, etc. John is also an excellent writer and is able to communicate his knowledge clearly and effectively. It has been my pleasure to co-author several publications with him. Strategically, John is adept at proactively identifying and effectively communicating potential pitfalls, providing multiple alternative options and providing very honest and realistic assessments of the potential advantages and disadvantages of any particular approach. He has a witty and insightful personality and is a pleasure to work with.

John has a broad-based drug discovery knowledge spanning from preclinical research to early clinical lead optimization to FIH regulatory submissions. While on a job rotation in the Global Regulatory Documentation group, John provided support in authoring regulatory documentation for IND dossiers, including those done in collaboration with external stakeholders. John is intelligent, dependable, focused and organized; he demonstrated an ability to work both independently as well as with a multi-functional team. Most importantly, his solid scientific background and industry knowledge allowed John to seamlessly fit into the new group environment and instantly make a significant contribution. John would make a valuable asset to any organization that pursues the discovery and development of new drugs. I would welcome an opportunity to work with John again in the future.

I worked with John for 8 years in Lead Discovery at BMS. John is an excellent scientist. He is among the most well-read and up-to-date on the relevant scientific literature of any scientists that I know. He not only has a deep understanding of GPCRs (I was struck by this the first time that I met him), but also a surprisingly broad knowledge around other target classes as well — kinases, ion channels, protein-protein interactions, RTKs, etc. John is also an excellent writer and is able to communicate his knowledge clearly and effectively. It has been my pleasure to co-author several publications with him. Strategically, John is adept at proactively identifying and effectively communicating potential pitfalls, providing multiple alternative options and providing very honest and realistic assessments of the potential advantages and disadvantages of any particular approach. He has a witty and insightful personality and is a pleasure to work with.